推薦產品
化驗
≥95% (of total lipoprotein content, electrophoresis)
品質等級
形狀
liquid
製造商／商標名
Calbiochem®
儲存條件
do not freeze
protect from light
運輸包裝
wet ice
儲存溫度
2-8°C
一般說明
A 10 mg vial contains ~2 mg of protein.
Native low density lipoproteins from human plasma. Cholesterol-carrier lipoprotein responsible for delivery of lipids (cholesterol) from liver to tissues. (Composition: 78-81% lipid; 19-22% protein. Note: 10 mg vial contains 2 mg of protein.)
包裝
Please refer to vial label for lot-specific concentration.
警告
Toxicity: Standard Handling (A)
外觀
In 150 mM NaCl, 0.01% EDTA, pH 7.4.
準備報告
Prepared from plasma that has been shown by certified tests to be negative for HBsAg and for antibodies to HIV and HCV.
重構
This product does not contain preservatives, so it is recommended that it be used under a laminar flow hood. Following initial use, this product is stable for 1 week at 2-8°C.
其他說明
Foster, J.D., et al. 1993. Endocrinology132, 337.
Retsky, K.L., et al. 1993. J. Biol. Chem. 268, 1304.
Fielding, C.J. 1992. FASEB J. 6, 3162.
Retsky, K.L., et al. 1993. J. Biol. Chem. 268, 1304.
Fielding, C.J. 1992. FASEB J. 6, 3162.
法律資訊
CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany
儲存類別代碼
12 - Non Combustible Liquids
水污染物質分類（WGK）
nwg
閃點（°F）
Not applicable
閃點（°C）
Not applicable
分析證明 (COA)
輸入產品批次/批號來搜索 分析證明 (COA)。在產品’s標籤上找到批次和批號，寫有 ‘Lot’或‘Batch’.。
客戶也查看了
Jiawei Chen et al.
The Biochemical journal, 393(Pt 1), 255-265 (2005-09-22)
LOX-1, a receptor for ox-LDL (oxidized low-density lipoprotein), has recently been determined to play a critical role in the progression of atherosclerosis. LOX-1 expression (mRNA and protein) has been shown to be up-regulated by pro-atherogenic stimuli, such as ox-LDL and
Jean Baptiste Nyandwi et al.
International journal of molecular medicine, 49(5) (2022-03-23)
Endothelial dysfunction during diabetes has been previously reported to be at least in part attributed to increased oxidized low‑density lipoprotein (oxLDL) levels mediated by high glucose (HG) levels. Endothelial inflammation increases the adhesiveness of monocytes to the endothelium in addition
Lee D Chaves et al.
JCI insight, 6(11) (2021-04-30)
Patients with chronic kidney disease (CKD) and end-stage renal disease suffer from increased cardiovascular events and cardiac mortality. Prior studies have demonstrated that a portion of this enhanced risk can be attributed to the accumulation of microbiota-derived toxic metabolites, with
我們的科學家團隊在所有研究領域都有豐富的經驗，包括生命科學、材料科學、化學合成、色譜、分析等.
聯絡技術服務